The Canadian Registry of Palivizumab (CARESS): Outcomes Following Twelve Seasons of RSV Prophylaxis

Time: 4:00 pm
day: Day Two

Details:

  • Review the CARESS study protocol and enrolment
  • Examine the indications for prophylaxis, palivizumab utilization and adherence
  • Review the respiratory and RSV-related hospitalizations across the indications from 2005-2017

Speakers: